DENTSPLY SIRONA Inc. (NASDAQ:XRAY) announced its earnings results on Friday. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.04, Bloomberg Earnings reports. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $978.99 million. During the same quarter in the prior year, the company earned $0.66 EPS. The business’s revenue was up 5.8% compared to the same quarter last year. DENTSPLY SIRONA updated its FY17 guidance to $2.65-2.70 EPS.

Shares of DENTSPLY SIRONA (NASDAQ:XRAY) opened at $64.80 on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.34 and a quick ratio of 1.55. The company has a market cap of $14,036.33, a P/E ratio of 24.76, a price-to-earnings-growth ratio of 2.51 and a beta of 1.27.

XRAY has been the subject of several research reports. HC Wainwright began coverage on DENTSPLY SIRONA in a research report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price for the company. Credit Suisse Group reaffirmed an “outperform” rating and set a $75.00 price objective (up previously from $67.00) on shares of DENTSPLY SIRONA in a research report on Thursday, July 13th. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price objective for the company in a research report on Thursday, July 13th. BidaskClub lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Wednesday, July 19th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $66.00 price objective (down previously from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $65.60.

TRADEMARK VIOLATION WARNING: This story was reported by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/11/03/dentsply-sirona-inc-xray-posts-earnings-results-beats-estimates-by-0-05-eps.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.